Magazine-How delays derailed Covid-19 vaccination in Africa
In this issue, we examine how delays derailed Covid-19 vaccination campaigns in Africa, China’s rapid progress in developing CAR-T therapies, how the bear market is affecting…
By
Follow @manasivaidya22
Manasi Vaidya is the lead editor for Pharmaceutical Technology where she covers the healthcare space. She writes features that look at the research, regulation and reimbursement of drugs with a focus on topics at the intersection of business and science. She is based in Brooklyn and an alum of New York University’s Science, Health and Environmental Reporting program.
In this issue, we examine how delays derailed Covid-19 vaccination campaigns in Africa, China’s rapid progress in developing CAR-T therapies, how the bear market is affecting…
By Manasi VaidyaWhile the task of disposing drugs in an eco-safe manner stumps many, drug take-back initiatives look to fill in…
By Manasi VaidyaThe use of Covid-19 drugs and the continued dominance of specialty drugs contributed to the rise in drug expenditures…
By Manasi VaidyaThe Russian invasion of Ukraine has knock-on effects on the Covid-19 pandemic as supplies of Sputnik V vaccine to…
By Manasi Vaidya and Fiona BarryIn this issue: We examine the supply chain for delivering Covid-19 antivirals, and the pharma industry's quest to decarbonise.
By Manasi VaidyaAn analysis of the demand for Covid-19 therapeutics allocation has shown that supply dynamics evolve slower than infection rates.
By Manasi Vaidya and Andrew HillmanIn this issue: Mapping research trends with RNA therapeutics and artificial intelligence in drug development for 2022, following the…
In order to improve diversity in trials, inequities due to economic factors and race need to be bridged at…
By Manasi VaidyaThe Swiss firm is advancing its cancer therapies in the clinic while it gears up to raise funds
By Manasi VaidyaThank you for subscribing to Pharmaceutical Technology